Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
140.00    -1.25 (-0.88%)
Bid:
137.00
Ask:
144.50
Spread: 7.50 (5.474%)
Market Cap: £109.86m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

19 Apr 2010 07:00

RNS Number : 3236K
Xaar PLC
19 April 2010
 



 

 

 

FOR IMMEDIATE RELEASE

19 April 2010

 

 

 

Xaar plc

 

 

INTERIM MANAGEMENT STATEMENT

 

 

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 January 2010 to 31 March 2010.

 

Trading and margins for the first quarter of the year were in line with the Board's expectations. Sales of Platform 1 ("P1") products have shown more stability than seen in recent periods and the increased demand for Platform 3 ("P3") products, first reported for the fourth quarter of last year, has continued. During Q1 2010, P3 demand continued to grow; the company is investing to increase output from the Huntingdon plant by mid-year.

 

The increase in P3 sales continues to be driven by volume sales into the industrial and packaging markets. We continue to work with our customers in these and other end markets to deliver levels of performance to allow them to move their printing machinery products to volume launch. We are still incurring some additional costs associated with new product introductions; however these are expected to reduce later this year as previously stated.

 

The consolidation of the Group's manufacturing facilities into a single plant in Huntingdon, England continues to progress according to schedule with the costs and benefits of the project remaining in line with the original plan.

 

The Group's balance sheet is strong with net cash at 31 March 2010 of £9.2m (31 December 2009: £11.1m).

 

The Board is encouraged by the rate of adoption of the Group's P3 products in new markets and remains satisfied with the relative stability of P1 sales in Xaar's traditional markets. The Board is now looking forward to volume sales of both P3 and new P1 products across a wider range of customers and end markets together with the reduction of new product support costs.

 

 

Ends

 

 

 

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Steve Liebmann or Andy Harris

020-7367-8883 / 07802-888159

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBBGDSBUBBGGL
Date   Source Headline
13th Mar 200810:21 amRNSDividend Payment Date
13th Mar 20087:01 amRNSFinal Results
19th Feb 20087:00 amRNSNotice of Final Results
8th Feb 20087:00 amRNSCustomer product launch
30th Jan 20087:00 amRNSDirectorate Change
29th Jan 20087:01 amRNSControl change for partner
10th Jan 20087:01 amRNSYear end trading update
9th Jan 20087:00 amRNSHolding(s) in Company
4th Jan 20083:59 pmRNSTotal Voting Rights
2nd Jan 20089:53 amRNSHolding(s) in Company
11th Dec 200712:25 pmRNSHolding(s) in Company
6th Dec 20075:17 pmRNSTotal Voting Rights
30th Nov 200710:26 amRNSHolding(s) in Company
30th Nov 20077:00 amRNSHolding(s) in Company
27th Nov 200710:12 amRNSHolding(s) in Company
31st Oct 20078:30 amRNSHolding(s) in Company
17th Oct 20076:36 pmRNSHolding(s) in Company
15th Oct 20077:00 amRNSAppointment of Director
5th Oct 20075:46 pmRNSDirector/PDMR Shareholding
12th Sep 20077:01 amRNSInterim Results
11th Sep 20077:03 amRNSNew customer product launches
4th Sep 20075:39 pmRNSTotal Voting Rights
3rd Sep 20077:02 amRNSNotice of Interim Results
21st Aug 20075:29 pmRNSHolding(s) in Company
17th Aug 20076:00 pmRNSHolding(s) in Company
17th Aug 20075:40 pmRNSHolding(s) in Company
6th Aug 20077:00 amRNSDirector/PDMR Shareholding
2nd Aug 20074:30 pmRNSTotal Voting Rights
17th Jul 20077:00 amRNSAppointment of R&D Director
13th Jul 200711:05 amRNSHolding(s) in Company
11th Jul 20077:00 amRNSTotal Voting Rights
11th Jul 20077:00 amRNSDirector/PDMR Shareholding
10th Jul 20077:00 amRNSPeriod End Trading Statement
9th Jul 20075:45 pmBUSDutton Associates Announces Investment Opinion: Xaar Plc Rated Buy in Update Report by Dutton Associates
4th Jun 200710:51 amRNSHolding(s) in Company
24th May 20076:11 pmRNSDirector/PDMR Shareholding
24th May 20071:10 pmRNSHolding(s) in Company
23rd May 20077:00 amRNSFacility visit
16th May 20077:01 amRNSAppointment of Chairman
14th May 20077:00 amRNSDirector/PDMR Shareholding
10th May 20076:05 pmRNSDirector/PDMR Shareholding
9th May 20076:19 pmRNSDirector/PDMR Shareholding
1st May 20076:24 pmRNSDirector/PDMR Shareholding
1st May 200711:37 amRNSHolding(s) in Company
24th Apr 200710:20 amRNSDirector/PDMR Shareholding
23rd Apr 200712:56 pmRNSResult of AGM
23rd Apr 20077:01 amRNSAGM Trading Update
13th Apr 20075:00 pmBUSDutton Associates Announces Investment Opinion: Xaar plc Buy Rating Maintained In Update Coverage By Dutton Associates
11th Apr 200711:55 amRNSAnnual Information Update
29th Mar 20071:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.